2021
DOI: 10.1016/j.puhip.2021.100205
|View full text |Cite
|
Sign up to set email alerts
|

The fight against the COVID-19 pandemic: Vaccination challenges in Sudan

Abstract: The first COVID-19 in Sudan was announced on March 13th, 2020. 1835 deaths were recorded as of February 7th, 2021. 800,000 doses of the Oxford-AstraZeneca vaccine were allocated to Sudan through COVAX in March, 2021. However, multiple challenges exist in vaccinating the Sudanese population, ranging from an inadequate cold chain system to low acceptance rates of COVID-19 vaccination among the Sudanese population. Economic crises, high inflation rates and long-standing economic sanctions have also negatively imp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(13 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“…To the best of our knowledge, this is the first report on the safety profile of COVID-19 vaccines in Sudan. The low vaccine acceptance in Sudan is a major barrier to implementing a successful vaccination campaign [ 15 , 19 , 20 ]. The available literature underscores that the fear of unknown side-effects is substantially linked with the low acceptability of COVID-19 vaccines in Sudan [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…To the best of our knowledge, this is the first report on the safety profile of COVID-19 vaccines in Sudan. The low vaccine acceptance in Sudan is a major barrier to implementing a successful vaccination campaign [ 15 , 19 , 20 ]. The available literature underscores that the fear of unknown side-effects is substantially linked with the low acceptability of COVID-19 vaccines in Sudan [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…The low vaccine acceptance in Sudan is a major barrier to implementing a successful vaccination campaign [ 15 , 19 , 20 ]. The available literature underscores that the fear of unknown side-effects is substantially linked with the low acceptability of COVID-19 vaccines in Sudan [ 14 , 15 ]. In this context, it is imperative to inform the general public regarding real-world data on the safety of COVID-19 vaccines.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“… 22 A possible attribution to these differences is likely the capital cities being the first point of distribution of COVID-19 vaccines through the COVAX program in developing countries. In Sudan, healthcare professionals are given the highest priority in receiving COVID-19 doses in the first phase of distribution, intended to cover 4% of the general population, in conjunction with over-45s with chronic morbidities 21 , 24 …”
Section: Discussionmentioning
confidence: 99%